Tenaya Therapeutics adopts 2024 Inducement Plan, reclassifies director to balance board

Tenaya Therapeutics, Inc.

Karah Parschauer reclassified from Class I to Class II director to balance board classes (3 per class).
Board reduced size to 9 directors; Parschauer's compensation unchanged, remains on Audit Committee.
Adopted 2024 Inducement Equity Incentive Plan, reserving 1,200,000 shares for new-hire inducement awards.
Plan intended as material inducement for new employees; no shareholder approval required under Nasdaq rules.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.